Vitamin E and omega 3 fatty acid in management of pain during menstruation

Role of vitamin E and omega 3 fatty acid in management of dysmenorrhea - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077424

Enrollment

360

Registered

2024-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

Intervention1: Vitamin E and Omega 3 fatty acid: 400 IU of vitamin E and 600 mg of omega 3 fatty acid (EPA and DHA) to be given orally from 5 days before the start of menstruation for total of 8 days

Eligibility

Inclusion criteria

Inclusion criteria: Females aged 18 to 45 years coming to Obstetrics and Gynaecology department with the diagnosis of dysmenorrhea

Exclusion criteria

Exclusion criteria: Patients with irregular menstrual cycles Patients requiring immediate surgical management Patients requiring immediate hormonal management Patients with active PID Patients with coagulopathy Patients taking opioid analgesic Patients on anticoagulants Patients with liver disease Patients with cardiac disease

Design outcomes

Primary

Measure	Time frame
Effect on average pain and maximum pain on VAS scale during menstruation in dysmenorrhea patients in 3 groupsTimepoint: 1 month, 2 months, 3 months	—

Secondary

Measure	Time frame
Total number of NSAID tablets taken during menstruation in dysmenorrhea patientsTimepoint: 1 month, 2 months, 3 months;Effect on menstrual blood flow ( PBAC) in three groupsTimepoint: 1 month, 2 months, 3 months	—

Countries

India

Contacts

Public ContactKanchan Rani

Teerthanker Mahaveer Medical College and Research Centre, Moradabad

drkanchanrani@gmail.com09756216630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026